1. Home
  2. SNTI vs IBG Comparison

SNTI vs IBG Comparison

Compare SNTI & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • IBG
  • Stock Information
  • Founded
  • SNTI 2016
  • IBG 2018
  • Country
  • SNTI United States
  • IBG Australia
  • Employees
  • SNTI N/A
  • IBG N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • IBG Beverages (Production/Distribution)
  • Sector
  • SNTI Health Care
  • IBG Consumer Staples
  • Exchange
  • SNTI Nasdaq
  • IBG Nasdaq
  • Market Cap
  • SNTI 10.4M
  • IBG 9.6M
  • IPO Year
  • SNTI N/A
  • IBG 2024
  • Fundamental
  • Price
  • SNTI $4.41
  • IBG $1.11
  • Analyst Decision
  • SNTI Strong Buy
  • IBG Strong Buy
  • Analyst Count
  • SNTI 1
  • IBG 1
  • Target Price
  • SNTI $12.00
  • IBG N/A
  • AVG Volume (30 Days)
  • SNTI 7.0M
  • IBG 1.0M
  • Earning Date
  • SNTI 11-14-2024
  • IBG 02-15-2025
  • Dividend Yield
  • SNTI N/A
  • IBG N/A
  • EPS Growth
  • SNTI N/A
  • IBG N/A
  • EPS
  • SNTI N/A
  • IBG N/A
  • Revenue
  • SNTI N/A
  • IBG $3,147,763.00
  • Revenue This Year
  • SNTI $254.47
  • IBG N/A
  • Revenue Next Year
  • SNTI $169.66
  • IBG N/A
  • P/E Ratio
  • SNTI N/A
  • IBG N/A
  • Revenue Growth
  • SNTI N/A
  • IBG N/A
  • 52 Week Low
  • SNTI $1.52
  • IBG $0.60
  • 52 Week High
  • SNTI $16.94
  • IBG $3.35
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 52.77
  • IBG N/A
  • Support Level
  • SNTI $4.62
  • IBG N/A
  • Resistance Level
  • SNTI $5.96
  • IBG N/A
  • Average True Range (ATR)
  • SNTI 1.63
  • IBG 0.00
  • MACD
  • SNTI -0.14
  • IBG 0.00
  • Stochastic Oscillator
  • SNTI 18.48
  • IBG 0.00

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About IBG Innovation Beverage Group Limited Ordinary Shares

Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.

Share on Social Networks: